首页> 美国卫生研究院文献>British Medical Journal >Risk of bias from inclusion of patients who already have diagnosis ofor are undergoing treatment for depression in diagnostic accuracy studies ofscreening tools for depression: systematic review
【2h】

Risk of bias from inclusion of patients who already have diagnosis ofor are undergoing treatment for depression in diagnostic accuracy studies ofscreening tools for depression: systematic review

机译:包含已经确诊患有糖尿病的患者而产生偏见的风险或正在接受抑郁症的诊断准确性研究抑郁症筛查工具:系统评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objectives To investigate the proportion of original studies included in systematic reviews and meta-analyses on the diagnostic accuracy of screening tools for depression that appropriately exclude patients who already have a diagnosis of or are receiving treatment for depression and to determine whether these systematic reviews and meta-analyses evaluate possible bias from the inclusion of such patients.>Design Systematic review.>Data sources Medline, PsycINFO, CINAHL, Embase, ISI, SCOPUS, and Cochrane databases were searched from 1 January 2005 to 29 October 2009.>Eligibility criteria for selecting studies Systematic reviews and meta-analyses in any language that reported on the diagnostic accuracy of screening tools for depression.>Results Only eight of 197 (4%) unique publications from 17 systematic reviews and meta-analyses specifically excluded patients who already had a diagnosis of or were receiving treatment for depression. No systematic reviews or meta-analyses commented on possible bias from the inclusion of such patients, even though 10 reviews used quality assessment tools with items to rate risk of bias from composition of the sample of patients.>Conclusions Studies of the accuracy of screening tools for depression rarely exclude patients who already have a diagnosis of or are receiving treatment for depression, a potential bias that is not evaluated in systematic reviews and meta-analyses. This could result in inflated estimates ofaccuracy on which clinical practice and preventive care guidelines are oftenbased, a problem that takes on greater importance as the rate of diagnosed andtreated depression in the population increases.
机译:>目的调查系统评价和荟萃分析中所包含的原始研究在抑郁症筛查工具的诊断准确性中所占的比例,这些工具适当地排除了已经诊断出或正在接受抑郁症治疗的患者,并确定这些系统评价和荟萃分析是否评估了纳入此类患者的可能偏倚。>设计系统评价。>数据来源 Medline,PsycINFO,CINAHL,Embase,ISI,SCOPUS和2005年1月1日至2009年10月29日的Cochrane数据库进行了搜索。>选择研究的资格标准以任何语言报告了抑郁症筛查工具的诊断准确性的系统评价和荟萃分析。 >结果来自17个系统评价和荟萃分析的197篇独特出版物中只有8篇(4%)明确排除了已经诊断出或已被接受的患者克治疗抑郁症。尽管有10条评论使用了质量评估工具,并用项目对患者样本构成的偏见风险进行评分,但没有系统的评论或荟萃分析对包括这些患者的偏见发表评论。>结论研究对于抑郁症筛查工具的准确性,很少将已经诊断出或正在接受抑郁症治疗的患者排除在外,而这种潜在的偏倚并未在系统的回顾和荟萃分析中进行评估。这可能会导致对通常在临床实践和预防保健指南上的准确性基于这个问题,随着诊断和治疗的抑郁症人口增加。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号